Efficacy and safety of hyaluronidase-facilitated subcutaneous immunoglobulin 10% in US pediatric patients with primary immunodeficiency disease
Patel, Niraj, Walter, Jolan, Wasserman, Richard, Rubinstein, Arye, Atkinson, T Prescott, Shepherd, Meagan, Greco, Erin, Russo-Schwarzbaum, Sharon, Duff, Kimberly, McCoy, Barbara, Chu, Liang-Hui, Li, Zhaoyang, Yel, Leman
Published in Clinical immunology (Orlando, Fla.) (01.05.2023)
Published in Clinical immunology (Orlando, Fla.) (01.05.2023)
Get full text
Journal Article
Pharmacokinetics, safety, and efficacy of 20% subcutaneous immunoglobulin (Ig20Gly) administered weekly or every 2 weeks in Japanese patients with primary immunodeficiency diseases: a phase 3, open-label study
Kanegane, Hirokazu, Endo, Akifumi, Okada, Satoshi, Ohnishi, Hidenori, Ishimura, Masataka, Nishikomori, Ryuta, Imai, Kohsuke, Nonoyama, Shigeaki, Muramatsu, Hideki, Wada, Taizo, Kuga, Atsushi, Sakamoto, Ko, Russo-Schwarzbaum, Sharon, Chu, Liang-Hui, McCoy, Barbara, Li, Zhaoyang, Yel, Leman
Published in Immunotherapy advances (01.01.2024)
Published in Immunotherapy advances (01.01.2024)
Get full text
Journal Article